Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners

被引:0
作者
Marcin Drozd
Ewa A. Jankowska
Waldemar Banasiak
Piotr Ponikowski
机构
[1] Wroclaw Medical University,Laboratory for Applied Research on Cardiovascular System, Department of Heart Diseases
[2] Military Hospital,Cardiology Department, Centre for Heart Diseases
[3] Wroclaw Medical University,Department of Heart Diseases
来源
American Journal of Cardiovascular Drugs | 2017年 / 17卷
关键词
Iron Deficiency; Heart Failure Patient; Iron Therapy; Iron Sucrose; Heart Failure With Reduce Ejection Fraction;
D O I
暂无
中图分类号
学科分类号
摘要
In patients with heart failure (HF), iron deficiency (ID) correlates with decreased exercise capacity and poor health-related quality of life, and predicts worse outcomes. Both absolute (depleted iron stores) and functional (where iron is unavailable for dedicated tissues) ID can be easily evaluated in patients with HF using standard laboratory tests (assessment of serum ferritin and transferrin saturation). Intravenous iron therapy in iron-deficient patients with HF and reduced ejection fraction has been shown to alleviate HF symptoms and improve exercise capacity and quality of life. In this paper, we provide information on how to diagnose ID in HF. Further we discuss pros and cons of different iron preparations and discuss the results of major trials implementing iron supplementation in HF patients, in order to provide practical guidance for clinicians on how to manage ID in patients with HF.
引用
收藏
页码:183 / 201
页数:18
相关论文
共 307 条
[1]  
Andrews NC(1999)Disorders of iron metabolism N Engl J Med 341 1986-1995
[2]  
Clark SF(2009)Iron deficiency anemia: diagnosis and management Curr Opin Gastroenterol. 25 122-128
[3]  
McLean E(2009)Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005 Public Health Nutr. 12 444-454
[4]  
Cogswell M(1994)Iron deficiency anaemia Gut 35 864-865
[5]  
Egli I(2006)The cardiomyopathy of iron deficiency Texas Hear Inst J 33 340-344
[6]  
Lundström U(2014)Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis Am J Nephrol 39 130-141
[7]  
Hegde N(2015)Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency Eur Heart J 36 657-668
[8]  
Rich MW(2009)Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 2436-2448
[9]  
Gayomali C(2011)Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival J Am Coll Cardiol 58 1241-1251
[10]  
Susantitaphong P(2013)Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives Eur Heart J 34 816-826